Question to the Department for International Trade:

To ask the Secretary of State for International Trade, whether she has mane an assessment of the impact of Britain’s trade negotiations with India on the ability to manufacture generic medicines for the NHS.

I am clear that I will never agree any provisions that would increase the cost of medicines for our National Health Service. Britain’s trade negotiations with India will not impact on the UK’s access to affordable medicines.